Categories Earnings

Earnings preview: Will Ford ride a bull in Q3?

The whole auto industry is going through an evolutionary period with high volatility and uncertainty, which is visible in all major stocks including Ford (F), General Motors (GM), Fiat Chrysler Automobiles (FACU) and Toyota Motors (TM). As Ford reports third-quarter earnings after market close on October 24, it will not only set the yardstick for the rest of the auto industry earnings this quarter but will also provide a glimpse of where the sector is headed.

Ford earnings preview
Photo by James & Carol Lee on Unsplash

The company has already dropped hints that it may see another revenue decline for the recently ended quarter, as it reported an 11% dip in September US auto sales. While SUVs and pickups continue to drive sales for Ford, demand and sale of sedans have been pretty sluggish recently.

The same goes for Ford rivals also. US sales of General Motors slipped 11% in Q3, while that of Toyota fell 6%. However, Fiat managed to buck this trend by posting a 10%  increase in sales in the third quarter.

Meanwhile, profits have not been dented much, as average transaction price per vehicle increased to $1,500. The automakers’ decision to cut a good portion of its workforce should also ensure enough liquidity within the stock.

China, Europe issues force Ford Q2 profit down

Investors are waiting to see how CEO Jim Hackett is planning to restructure the company and would be keenly listening for any hints on the same. The impact of the US-China trade war on the production and distribution of goods into the Asian market is also likely to be discussed during the Q3 earnings conference call.

Ford shares have shed 32% of its value during the year-to-date period.

 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top